Synthesis and Biological assessment in Pyridazine analogues

Two nitrogen atoms are located adjacent to one another in the five-membered heterocyclic compound known as pyrazole. There are several chemotherapeutic uses for pyrazole-tethered heterocyclic molecules. Numerous other biological activities, including those that were anti-inflammatory, anti-bacterial, anti-malarial, anti-hypertensive, anti-tubercular, antiviral, neuroprotective, antidepressant, and anti-cancer, were also found. Many pyrazole substances have been tried in clinical trials, and some of them have been useful in the development of potent chemotherapy medicines. The market is flooded with pyrazole-based drugs, including Celecoxib, Apixaban, Fipronil, Betazole, Tepoxalin, Fezolamine, Pyrazomycin, Fomepizole, Mepirizole, Difenamizole, Lonazolac, Tolpiprazole, Crizotinib, Ruxolitinib, and many more. [1] There are two popular pyrazole-based anticancer medications: crizotinib and roxolitinib. Prostate cancer experimental models have revealed that celecoxib has an anticancer effect. Numerous cancer cells, including those from the breast, prostate, lungs, and stomach, were shown to have undergone apoptosis. Pyrazoles have the potential to treat cancer by suppressing the following proteins: EGFR, topoisomerase II, VEGF, HDAC, IGF-1R, Aurora-A kinase, cMet, tubulin, mTOR, B-raf, ROS1, CDKs, PI3K, and JAK2. For the action of non-small cell lung cancer, crizotinib is a dual cMet/ALK inhibitor. Myeloproliferative neoplasm is treated with roxolitinib, (JAK2). ainclusivevariety of fascinating pyrazoles have been created as potential chemotherapeutic agents. [2] Compound 1 shows anticancer action against NCIH460, OVCA, AGS, and SW620 human cancer cells, with GI50 values of 0.73, 0.67, 0.79, and 0.89 M, respectively. With the chemical formula C4H4N2, pyridazine (Figure 1), commonly known as 1, 2-diazine, is a heteroaromatic organic molecule. The CAS number for it is 289-80-5. There are 80.09 g mol-1 in its molar mass. Pyridazine weighs 1.107 grammes per cubic centimetre. 1, 2-diazine, orthodiazine, and oizine are some of its alternate names. [3]

Figure 1: Structure of pyridazine Pyridazine has a boiling point of 207°C and is an inert liquid. With protic solvents and benzene, hydrogen bonds are formed via the lone pair on the nitrogen atom. Basicity is strengthened by electron donating groups, and it is mildly basic (pKa-2.3). Thus, the pKa value of 4-methyl pyridazine is 2.93. The dipole moment of pyridazine is 3.9 Debye. [4]

The pyridine-like molecule of pyridazine is a -deficient substance. When compared to other hydrocarbons, these molecules are more soluble in water because they contain -deficient nitrogen aromatic heterocycles. Pyridazine has two nearby nitrogen atoms in its fundamental aromatic ring structure. The chemistry of this molecule is made special by the nitrogen atoms. [5]

These compounds can interact with a suitable substrate due to the numerous nitrogen atoms present in them.

There are six potential reduced Pyridazines, with the pyridazine presumed to be a planar six-membered ring. (Figure 5).

(figure 6). In contrast to the 4- and 6-hydroxypyridazine-1-oxide, which are mostly found in the N-hydroxy pyridazinone forms, the 3- and 5-hydroxypyridazine-1-oxides occur in the hydroxyl-N-oxide forms (Figure 7). [6]

i. Reaction with Acids:Being a weak base, pyridazine reacts with mineral acids to create salts. It takes a lot of energy to produce two positive charges on nearby atoms, making it challenging to protonate the second nitrogen atom. [7] ii. Quaternization:Although less often than pyridine, the pyridazine ring can produce mono quaternary salts by reacting with an alkyl halide or dialkyl sulphate in the presence of a base. Alkyl groups on the ring have a role in where monoalkylation takes place. The alkylation of 4-methylpyridazine is directed to N-1 position in the subsequent reaction by the methyl group. [8]

iii. Electrophilic Substitution:Due to the inductive influence of nitrogen atoms, the pyridazine nucleus is electron-deficient at locations 3, 4, 5, and 6. Sincepyridazine itself is extremely resistant to electrophilic substitution, reaction only occurs under extreme circumstances. There haven't been any reports of pyridazine being sulfonated or nitrated. Additionally, it is not anticipated that the

iv. Reaction with Nucleophilic reagents:In general, the effect of nucleophilic reagents on the diazine is extremely sensitive. The inclusion of a second nitrogen atom has the effect of depleting the carbon atoms in the ring's ring even more electrons than they already are than they were in the pyridine. The direct displacement of the halo groups with concentrated ammonia or amines results in aminopyridazines, which are then synthesised. At the C-3 Position, pyridazine and organolithium do, however, react. [10]

Three-chloro-6-(3-hydroxyamino) pyridazine is produced via the arylation of 3,6-dichloropyridazine by strong aromatic nucleophiles such 3-aminophenol.

v. Reaction with Oxidising and Reducing Agents:Due to an electron shortage in the ring, pyridazine is also immune to the attack of oxidising agents. However, when using hydrogen peroxide, N-oxide is formed but no di-N- oxide is produced. [11]

The chemistry of natural substances is a common source of lead structures. Very, there are surprisingly few natural chemicals that have the usual N-N bond seen in pyridazine molecules. Most of them are isolated from broths used to cultivate Streptomyces. The novel antifungal drug Pyridazomycin (Figure 12),

The phenyl moiety is included in the construction of around 50% of medicinal compounds. Many thousands of diazaequivalents are now accessible thanks to the substitution of these phenyl rings with pyridazines. Additional interaction opportunities are made possible by using pyridazine scaffolds rather than phenyl scaffolds. Pyridazine derivatives have been shown to have anti-cancer, antihypertensive, anti-allergic, anti-histaminic, eosinophil chemotaxis-inhibiting, anti-inflammatory, anti-PAF (platelet-activating factor) activity, anti-HIV activity, anti-histaminic, and similar properties. They are also useful as an agent for preventing or treating asthma, allergic rhinitis, allergic conjunctivCredazine (Figure 13), pyridafol (Figure 14), pyridate (Figure 15), and maleic hydrazide are only a few herbicides that have the pyridazine structure (Figure16). Several pharmaceutical medications, including cilazapril, cadralazine, minaprine, hydralazine, and cefozopran, also include pyridazine in their structural makeup (Figure 21). A magic moiety with a wide range of biological functions is pyridazine-3-one. NSAIDs with a pyridazine nucleus are being developed with more urgency. [13]

The biological reaction of vascular tissues to damaging stimuli, such as irritants, infections, or damaged bodily cells, is inflammation. If left untreated, inflammation triggers the development of conditions including atherosclerosis, rheumatoid arthritis, and vasomotor rhinorrhea. Proinflammatory cytokines including vascular endothelial growth factor (VEGF), interleukin 1L-1, and tumour necrosis factor (TNF)- are present throughout the dynamic process of inflammation. [14] Multiple assays have been performed to compare the effectiveness of different NSAIDs; the findings show that the vast majority of these drugs are more effective against COX-1 than COX-2. Proven anti-inflammatory effects have been shown with MAP kinase inhibitors, glutathione S-transferase (GST) inhibitors, and inhibitors of nuclear factor kappa B

The development of novel, multi-resistant bacterial stains has been caused by the recent rise in antibiotic-resistant strains of clinically significant pathogens. There is a need to search for chemicals from other sources as a result. Because pyridazineresultsmustproven to have potent antibacterial and antifungal properties, they can serve as a source of novel antimicrobial chemicals. [16] The term "antimicrobial" is used to describe a wide variety of substances used to kill germs. There is a wide range of antibacterial activity and mechanisms of action among them. Most of them exhibit distinctive pharmacological and physicochemical properties. Anti-infective drugs have been used for centuries to save many lives. Chemotherapy for bacterial infections is more common among anti-infectives than anti-fungal, antiviral, and antiparasitic treatments. Modern human society is largely the product of this knowledge. In 1910, Ehrlich developed the first successful antibiotic, Salvarsan (Figure 24). Since then, antibiotics from other classes, such penicillins, sulphonamides, and beta-lactams, have shown the most promise. [17]

bacterial illnesses is among the most important developments in medicine during the past half-century. There are other ways to classify antibiotics, but the most prevalent is based on their chemical structures. Antibiotics come in many forms; some of the most common include sulphonamides, oxazolidinones, and glycopeptides.. [18]

• Reduction in cell wall formation

• Impairment of cell membrane structure or function

• Blocking the formation and activity of nucleic acids

• protein synthesis inhibition

• Blockage of key metabolic pathways

• Disruption and increased permeability of cytoplasmic membranes

Scientific intervention is needed to implement some control measures since resistance to antimicrobial drugs has been found to be a significant barrier to the clinical treatment and cure of many illnesses. There are just a few ways for microbes to develop antibiotic resistance. The most important survival methods that a threatened microbial population might utilise are genetic mutation, the appearance of a dormant resistance gene, and the acquisition of genes that contain resistance determinants. Some of the genes are inherited, while others appear as the result of chance changes in the DNA of microbes.[19]However, the discovery of bacterial antibiotic resistance calls into question the therapeutic utility of currently existing drugs and needs the creation of new antibacterial substances. The progressive chemistry-based augmentation of existing antibiotics is one example, and genomic-based searches for possible therapeutic targets are only two of the many ways that have arisen to uncover novel pharmacological targets. Finding new chemical compounds to study is essential for developing new medicines. This approach to drug discovery is explained with reference to drug design principles and recent developments in synthetic medicines or compounds. [20]

have produced 1, 2, and 3-trizole derivatives in high yields. One-pot operation, easy work-up, good yields, shorter reaction time, and absence of column chromatographic purification are some of this reaction's key benefits. Antimicrobial properties against several strains of bacteria and fungus were tested for in all freshly synthesised compounds. As a consequence, certain synthetic substances demonstrated moderate to good antimicrobial efficacy against various types of bacteria and fungus when compared to traditional medications.

REFERENCES

1. Asif M. Recent efforts for the development of anti-tubercular drug containing diazines ring. Medicinal Chemistry. 2012a; 2: 151-67. 2. Purohit V, Basu AK. Mutagenicity of nitroaromatic compounds. Chemical Research in Toxicology. 2001; 13: 673-92. 3. Ahsan MJ, Rathod VPS, Singh M, Sharma R, Jadav SS, Yasmin S, Salahuddin, Kumar P. Synthesis, Anticancer and molecular docking studies of 2-(4- chlorophenyl)-5-aryl-1,3,4-oxadiazole analogues. Medicinal Chemistry. 2013; 3: 294 7. 4. Mirzoeva S, Sawkar A, Zasadzki GL, Velentza AV, Dunlap V, Bourquiqnon JJ, Ramsirom H, Haiech J, Van Eldik LJ, Watterson DMJ. Discovery of a 3-amino-6- phenyl pyridazine derivative as a new synthetic anti-inflammatory compound. Journal of Medicinal Chemistry. 2002; 45: 563-6. 5. Behalo MS, El-karim IAG, Yvette AI, Farag M. Synthesis of novel pyridazinederivatives as potential antimicrobial agents. Journal of Sulphur Chemistry. 2014; 35: 661-3. 6. Shimizu H, Tanaka S, Toki T, Yasumatsu I, Akimoto T, Morishita K, Yamasaki T, Yasukoti T, Limura S. Discovery of imidazo[1,2-b]pyridazine derivatives as IKKβ inhibitors. Part 1: Hit-to-lead study and structure-activity relationship. Bioorganic and Medicinal Chemistry Letters. 2010; 20: 5113-8. 7. Akinsulire OR, Aibinu IE, Adenipekun T, Odugbemi T. In vitro antimicrobial activity of crude extracts from plants Bryophyllum pinnatum and Kalanchoecrenata. African 8. Takaya M, Sato M. Studies on Pyridazinone Derivatives. XVI. Analgesic-anti- inflammatory activities of 3(2H)-pyridazinone derivatives. Journal of Pharmaceutical Society of Japan. 2008; 114: 94-110. 9. Babahedari AK, Shamsabadi K, Kabiri HR, Tavakoli. Docking studies of competitive interaction of human serum albumin with ibuprofen and aspirin using the HEX docking software. Journal of Emerging Trends and Computer Information Sciences. 2013; 4(1): 97-9. 10. Zaher AA, Khalil OM, Refaat HM. Synthesis and anti-inflammatory activities of certain benzothieno [3,2-d][1,2,4]triazolo[4,3-b]pyridazine derivatives. Medicinal Chemistry Research. 2012; 21: 3146-53. 11. Rekha S, Chandrashekhar S, Bisht P, Vineetchandy. Synthesis, characterization and evaluation of in vitro and in vivo anti-inflammatory activity of novel benzimidazole derivatives. International Journal of Pharmacy and Life Sciences. 2013; 4: 2794-9. 12. Nossier ES, Fahmy HH, Khalifa NM, El-Eraky WI, Baset MA. Design and synthesis of novel pyrazole-substituted different nitrogenous heterocyclic ring systems as potential anti-inflammatory agents. Molecules. 2017; 22: 1-16. 13. Attanasi OA, Favi G, Filippone P, Perrulli FR and Santeusanio S. A novel and convenient protocol for synthesis of pyridazines. Organic Letters. 2009; 11: 309– 12. 14. Morris CJ. Carrageenan Induced paw edema in rat and mouse. Methods in Molecular Biology. 2003; 225: 115-21. 15. Banoglu E, Akoglu C, Unlu S, Kupeli E, Yesibda E, Sachin MF. Amide derivatives of [6-(5-methyl-3-phenylpyrazole-1-yl)-3-(2H)-pyridazinone-2-yl) acetic acids as potential analgesic and anti-inflammatory compounds. Archiv der Pharmazie. 2004; 337:7-14. 16. Liwa AC, Jaka H. Antimicrobial resistance: Mechanisms of action of antimicrobial agents. In: Vilas M, editor. The Battle Against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs. Spain: Formatex Research Center; 2015. p. 876-85. 17. Alfini R, Cecchi M, Giomi D. Reactivity and 18. Katritzky AR, Ramsden CA, Joule JA, Zhdankin VV. Handbook of Heterocyclic Chemistry. 3rd ed. Elsevier: Oxford; 2010 19. Bansal, RK. Heterocyclic Chemistry. 4th ed. New Age International Publishers: New Delhi; 2007. 20. Al-Harbi NO, Bahashwan SA, Fayed AA, and Ramadan MA. Pharmacological activities evaluation of some new pyrazolo-pyrimidino-pyridazine derivatives. African Journal of Pharmacy and Pharmacology. 2013; 7: 517-23.

Research Scholar, Shri Krishna University, Chhatarpur M.P.